BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 27198666)

  • 1. RIG-like Helicase Regulation of Chitinase 3-like 1 Axis and Pulmonary Metastasis.
    Ma B; Herzog EL; Moore M; Lee CM; Na SH; Lee CG; Elias JA
    Sci Rep; 2016 May; 6():26299. PubMed ID: 27198666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-13Rα2 uses TMEM219 in chitinase 3-like-1-induced signalling and effector responses.
    Lee CM; He CH; Nour AM; Zhou Y; Ma B; Park JW; Kim KH; Dela Cruz C; Sharma L; Nasr ML; Modis Y; Lee CG; Elias JA
    Nat Commun; 2016 Sep; 7():12752. PubMed ID: 27629921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CHI3L1 regulates PD-L1 and anti-CHI3L1-PD-1 antibody elicits synergistic antitumor responses.
    Ma B; Akosman B; Kamle S; Lee CM; He CH; Koo JS; Lee CG; Elias JA
    J Clin Invest; 2021 Nov; 131(21):. PubMed ID: 34720089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of chitinase 3-like-1 and semaphorin 7a in pulmonary melanoma metastasis.
    Ma B; Herzog EL; Lee CG; Peng X; Lee CM; Chen X; Rockwell S; Koo JS; Kluger H; Herbst RS; Sznol M; Elias JA
    Cancer Res; 2015 Feb; 75(3):487-96. PubMed ID: 25511377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of chitinase-3-like-1 in T cell elicits Th1 and cytotoxic responses to inhibit lung metastasis.
    Kim DH; Park HJ; Lim S; Koo JH; Lee HG; Choi JO; Oh JH; Ha SJ; Kang MJ; Lee CM; Lee CG; Elias JA; Choi JM
    Nat Commun; 2018 Feb; 9(1):503. PubMed ID: 29403003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CHI3L1 enhances melanoma lung metastasis
    Ma B; Kamle S; Akosman B; Khan H; Lee CM; Lee CG; Elias JA
    Front Immunol; 2022; 13():1056397. PubMed ID: 36618349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chitinase 3-like 1-CD44 interaction promotes metastasis and epithelial-to-mesenchymal transition through β-catenin/Erk/Akt signaling in gastric cancer.
    Geng B; Pan J; Zhao T; Ji J; Zhang C; Che Y; Yang J; Shi H; Li J; Zhou H; Mu X; Xu C; Wang C; Xu Y; Liu Z; Wen H; You Q
    J Exp Clin Cancer Res; 2018 Aug; 37(1):208. PubMed ID: 30165890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chitinase 3-like 1 regulates cellular and tissue responses via IL-13 receptor α2.
    He CH; Lee CG; Dela Cruz CS; Lee CM; Zhou Y; Ahangari F; Ma B; Herzog EL; Rosenberg SA; Li Y; Nour AM; Parikh CR; Schmidt I; Modis Y; Cantley L; Elias JA
    Cell Rep; 2013 Aug; 4(4):830-41. PubMed ID: 23972995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A small molecule targeting CHI3L1 inhibits lung metastasis by blocking IL-13Rα2-mediated JNK-AP-1 signals.
    Lee YS; Yu JE; Kim KC; Lee DH; Son DJ; Lee HP; Jung JK; Kim ND; Ham YW; Yun J; Han SB; Hong JT
    Mol Oncol; 2022 Jan; 16(2):508-526. PubMed ID: 34758182
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    He CH; Lee CG; Ma B; Kamle S; Choi AMK; Elias JA
    Am J Respir Cell Mol Biol; 2020 Sep; 63(3):386-395. PubMed ID: 32402213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-recruited M2 macrophages promote gastric and breast cancer metastasis via M2 macrophage-secreted CHI3L1 protein.
    Chen Y; Zhang S; Wang Q; Zhang X
    J Hematol Oncol; 2017 Feb; 10(1):36. PubMed ID: 28143526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paralysis of the cytotoxic granule machinery is a new cancer immune evasion mechanism mediated by chitinase 3-like-1.
    Darwich A; Silvestri A; Benmebarek MR; Mouriès J; Cadilha B; Melacarne A; Morelli L; Supino D; Taleb A; Obeck H; Sustmann C; Losurdo A; Masci G; Curigliano G; Kobold S; Penna G; Rescigno M
    J Immunother Cancer; 2021 Nov; 9(11):. PubMed ID: 34824159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chitinase 3-Like 1 Promotes Candida albicans Killing and Preserves Corneal Structure and Function by Controlling Host Antifungal Responses.
    Gao N; Yu FS
    Infect Immun; 2015 Oct; 83(10):4154-64. PubMed ID: 26238714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Chitinase 3-Like-1 in Interleukin-18-Induced Pulmonary Type 1, Type 2, and Type 17 Inflammation; Alveolar Destruction; and Airway Fibrosis in the Murine Lung.
    Kang MJ; Yoon CM; Nam M; Kim DH; Choi JM; Lee CG; Elias JA
    Am J Respir Cell Mol Biol; 2015 Dec; 53(6):863-71. PubMed ID: 25955511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Galectin-3 Interacts with the CHI3L1 Axis and Contributes to Hermansky-Pudlak Syndrome Lung Disease.
    Zhou Y; He CH; Yang DS; Nguyen T; Cao Y; Kamle S; Lee CM; Gochuico BR; Gahl WA; Shea BS; Lee CG; Elias JA
    J Immunol; 2018 Mar; 200(6):2140-2153. PubMed ID: 29427412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous galectin-3 expression levels modulate immune responses in galectin-3 transgenic mice.
    Chaudhari AD; Gude RP; Kalraiya RD; Chiplunkar SV
    Mol Immunol; 2015 Dec; 68(2 Pt A):300-11. PubMed ID: 26442663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chitinase 3-like-1 deficient donor splenocytes accentuated the pathogenesis of acute graft-versus-host diseases through regulating T cell expansion and type I inflammation.
    Li Z; Gu J; Liu J; Zhu Q; Lu H; Lu Y; Rao J; Lu L; Wang X
    Int Immunopharmacol; 2017 May; 46():201-209. PubMed ID: 28324830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of NLRX1 in chronic obstructive pulmonary disease.
    Kang MJ; Yoon CM; Kim BH; Lee CM; Zhou Y; Sauler M; Homer R; Dhamija A; Boffa D; West AP; Shadel GS; Ting JP; Tedrow JR; Kaminski N; Kim WJ; Lee CG; Oh YM; Elias JA
    J Clin Invest; 2015 Jun; 125(6):2458-62. PubMed ID: 25938787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chitinase 3-like-1, a novel regulator of Th1/CTL responses, as a therapeutic target for increasing anti-tumor immunity.
    Kim DH; Choi JM
    BMB Rep; 2018 May; 51(5):207-208. PubMed ID: 29699605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of proinflammatory mediators by CHI3L1 is reduced by chitin treatment: decreased tumor metastasis in a breast cancer model.
    Libreros S; Garcia-Areas R; Shibata Y; Carrio R; Torroella-Kouri M; Iragavarapu-Charyulu V
    Int J Cancer; 2012 Jul; 131(2):377-86. PubMed ID: 21866546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.